Template:COVID Dex: Difference between revisions
Elcatracho (talk | contribs) |
Ostermayer (talk | contribs) (Prepared the page for translation) |
||
| Line 1: | Line 1: | ||
====[[Dexamethasone]]==== | <languages/> | ||
<translate> | |||
====[[Special:MyLanguage/Dexamethasone|Dexamethasone]]==== | |||
*Dosage: 6mg Qday for 10 days | *Dosage: 6mg Qday for 10 days | ||
**Dexamethasone improves 28d mortality compared to placebo in patients requiring IMV (NNT = 8.5) and those patients requiring oxygen therapy (NNT = 29). | **Dexamethasone improves 28d mortality compared to placebo in patients requiring IMV (NNT = 8.5) and those patients requiring oxygen therapy (NNT = 29). | ||
**There was no benefit to patients not requiring oxygenation support and potentially harm | **There was no benefit to patients not requiring oxygenation support and potentially harm | ||
</translate> | |||
Revision as of 07:59, 26 January 2026
Dexamethasone
- Dosage: 6mg Qday for 10 days
- Dexamethasone improves 28d mortality compared to placebo in patients requiring IMV (NNT = 8.5) and those patients requiring oxygen therapy (NNT = 29).
- There was no benefit to patients not requiring oxygenation support and potentially harm